President Draupadi Murmu on April 4 launched India's first indigenously developed CAR T-cell therapy for the treatment of cancer, hailing it as a “major breakthrough” that will be “for mankind” in the fight against the disease. Provides “new hope”. During the launch event organized at the Indian Institute of Technology (IIT) Bombay in Powai, Mumbai, he also said that the development of this therapy is an example of 'Make in India' initiative.
This gene-based therapy developed by IIT Bombay and Tata Memorial Center will help in curing various types of cancer. This NexCAR19 CAR T-cell therapy is the country's first 'Made in India' CAR T-cell therapy, which will significantly reduce the cost of cancer treatment.
